Latest Share Chat

ABC.L Share News (ABC)

ABC.L Information

There is currently no data for ABC

Horizon Discovery Rejects GBP270.0 Million Proposal From Abcam

Wed, 02nd May 2018 16:41

LONDON (Alliance News) - Abcam PLC on Wednesday said gene editing company Horizon Discovery Group PLC has rejected its acquisition proposal.

The life science e-commerce company said it proposed a possible offer for Horizon at a value of 181.00 pence per share to buy Horizon's entire share capital, with the offer valuing Horizon at GBP270.0 million.

The proposal price represents about 26% premium compared to Horizon's closing share price of 144.00p on Tuesday, Abcam said.

Shares in Horizon closed 31% higher at 190.00p per share on Wednesday, while Abcam shares closed up 2.6% at 1,248.00p each.

More News

28 Apr 2014 15:15

DIRECTOR DEALINGS: ABCAM Executive And Wife Sell Shares

LONDON (Alliance News) - ABCAM PLC said Monday that Chief Information Officer Ed Ralph sold 10,000 shares, and his wife Victoria Ralph sold 10,000 shares, all at 390.25 pence each. Following this transaction Ralph has a 0.17% interest in the biotechnology company. Shares in ABCAM were

28 Apr 2014 14:15

DIRECTOR DEALINGS: Abcam Executives Awarded Shares

LONDON (Alliance News) - Abcam PLC Monday said Scientific Director Mark Bushfield and Commercial Director Philippe Cotrel were awarded matching shares at no cost under the share incentive plan.

Details are as follows.

24 Apr 2014 11:16

DIRECTOR DEALINGS: Abcam Chief Marketing Officer Buys Shares

LONDON (Alliance News) - Abcam PLC said Thursday that Chief Marketing Officer Alan Hirzel purchased 8,000 shares at a price of 387.89 pence per share on Wednesday. Following this transaction, Hirzel's interest in the protein tool supplier is 8,306 shares, representing 0.01% of the company's

23 Apr 2014 15:31

DIRECTOR DEALINGS: Abcam Non-Executive Buys Shares

LONDON (Alliance News) - Abcam PLC said Wednesday that Non-Executive Director Murray Hennessy purchased 12,800 shares at a price of 389.25 pence per share. The purchase represents Hennessy's only holding in the bio-pharmaceutical company. Abcam shares closed at 385.75 pence per share

22 Apr 2014 05:12

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

17 Apr 2014 15:19

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

17 Apr 2014 05:16

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

16 Apr 2014 15:15

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

16 Apr 2014 05:10

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

15 Apr 2014 14:39

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

15 Apr 2014 05:12

UK Dividends Calendar - Week Ahead

14 Apr 2014 15:04

UK Dividends Calendar - Week Ahead

14 Apr 2014 05:10

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

11 Apr 2014 15:50

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

10 Apr 2014 16:18

Abcam CEO builds family holding

Protein research tool developer Abcam on Thursday said that the wife of its Chief Executive Officer (CEO), Jonathan Milner, purchased 18,000 shares. Roza Gounari spent 373p a share for a total of £67,140. The deal takes Milner's stake in the group to around 13.8% of the issued share capital. J

Latest Share Chat

ABC.L Share News (ABC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Horizon Discovery Rejects GBP270.0 Million Proposal From Abcam

Login to your account

Quickpicks are a member only feature

Login to your account